Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China flag China · Delayed Price · Currency is CNY
28.03
-0.74 (-2.57%)
Sep 11, 2026, 3:00 PM CST

SHA:688076 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2,0341,9431,6251,034651.29643.87
Revenue Growth
10.46%19.57%57.21%58.69%1.15%13.58%
Gross Profit
1,1151,1331,050589.28343.36337.57
Operating Income
533464.03460.86191.0471.78117.1
Net Income
237.42332.42404.39162.94129.11115.39
Earnings Per Share
0.751.061.310.540.440.43
EPS Growth
-52.39%-19.08%141.30%24.60%1.66%-22.07%

Revenue by Geography

Fiscal YearFY 2025
Period EndingDec '25
China
576.96
Overseas
1,366
Total
1,943

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
956.791,030779.39749.08442.98679.01
Total Debt
2,8322,6601,642895.07320.1983.65
Net Cash (Debt)
-1,875-1,630-863.06-145.98122.79595.36
Net Cash Growth
-----79.38%-
Net Cash Per Share
-5.93-5.20-2.80-0.490.412.21

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
675.32681.24400.12350.2129.29180.75
Capital Expenditures
-1,061-1,367-1,090-660.64-438.36-233.36
Free Cash Flow
-385.97-685.77-690.01-310.43-409.07-52.61
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
54.84%58.34%64.61%57.02%52.72%52.43%
Operating Margin
26.20%23.89%28.36%18.48%11.02%18.19%
Pretax Margin
12.76%18.56%26.99%16.75%18.91%19.53%
Profit Margin
11.67%17.11%24.89%15.77%19.82%17.92%
FCF Margin
-18.97%-35.30%-42.47%-30.04%-62.81%-8.17%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.3500.3500.6430.2860.1430.107
Dividend Per Share Growth
-56.25%-45.56%125.03%99.93%33.43%-
Dividend Yield
1.22%0.94%1.78%0.92%0.91%0.38%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
37.3435.8428.2258.8137.8876.36
Forward PE
-17.4420.2550.6531.8642.28
PS Ratio
4.366.137.029.277.5113.68